Galderma stock: Shareholders approve dividend and board elections
Published on 11/02/2026 at 10:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAGM Decisions Shape Shareholder Returns
- Shareholders approved a gross dividend of CHF 0.35 per dividend-bearing share.
- Harry Kirsch joined the board as an independent member, while two L'Oreal representatives were elected as non-independent members.
- The meeting also approved Galderma's 2025 financial, non-financial and compensation reports.
Galderma shareholders approved all proposals submitted by the board at the company's annual general meeting on April 22, 2026, in Zug, Switzerland. The resolutions included a gross dividend of CHF 0.35 per dividend-bearing share, according to a Galderma press release.
Dividend Approval Supports Shareholder Returns
The distribution was approved from reserves from capital contributions. Galderma said the payment would be made in accordance with applicable tax rules, with the distribution free from Swiss withholding tax under the conditions stated in the release.
The dividend decision reinforces Galderma's shareholder-return profile, although the payment is a historical AGM resolution rather than a new market catalyst on November 2. Investors will therefore weigh the decision alongside the dermatology group's operating performance and outlook.
Board Composition Changes
Shareholders elected Harry Kirsch as an independent board member. Samuel du Retail and Delphine Viguier-Hovasse, representatives of L'Oreal, joined the board as non-independent members.
Thomas Ebeling, Daniel Browne, Maria Teresa Hilado, Karen Lee Ling, Roberto Marques, Sherilyn McCoy and Flemming Ornskov were re-elected. The vote preserves continuity while adding the newly elected directors to the governing body.
Reports Receive Shareholder Backing
The AGM also approved Galderma's 2025 annual financial statements, non-financial report and compensation report. The company said detailed voting results and the official minutes would be published on its investor-relations website within two weeks of the meeting.
Galderma stock traded at 209.00 euros on Lang & Schwarz at 10:10 CET on Monday, November 2, 2026. Investors can follow the real-time quote of Galderma stock.
Galderma Group AG at a Glance
- Company: Galderma Group AG
- ISIN: CH1335392721
- Home exchange: SIX Swiss Exchange
- Ticker: GALD
- Lang & Schwarz quote: 209.00 euros, November 2, 2026, 10:10 CET
The SMI provides the relevant Swiss market backdrop for investors following Galderma and other major Swiss-listed companies; see current SMI market coverage.
For further developments, see More news and analyses on Galderma stock.
